Duplicate and professional clinical trial participants can endanger themselves and may contribute to failure of an entire study. SubjectRegistry.com provides a single access point to the two largest and most experienced registries of clinical trial subjects. Professional subjects and dual enrollers may then be identified and eliminated to promote patient safety and the success of clinical trials.

CTSdatabase has over a hundred thousand subjects in their database and has been successfully detecting dual enrollers since 2011. Working as SubjectRegistry.com, investigators and sponsors are provided with a huge database of Phase 1-4 subjects and the greatest chance of detecting dual enrollers.

Once a clinical trial subject is entered on SubjectRegistry.com, investigators are immediately provided with a report detailing any matching subjects or dual enrollment. Sponsors also receive notification of exclusionary matches so that dual enrollers can be identified and removed before randomization.

HIPAA- and 21CFR 11- compliant, CTSdatabase provides an environment where subject identity cannot be ascertained. Data is maintained securely in this database and the privacy of both subjects and sponsors are protected.